|
Volumn 11, Issue 5, 2001, Pages 273-275
|
Antiviral drugs with extra-cellular sites of action
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ACICLOVIR;
ADEFOVIR;
ANTIVIRUS AGENT;
CD4 ANTIGEN DERIVATIVE;
CD4 IMMUNOGLOBULIN G2;
CIDOFOVIR;
CYTOCHROME P450 INHIBITOR;
DIDANOSINE;
ENFUVIRTIDE;
FAMCICLOVIR;
GANCICLOVIR;
HYBRID PROTEIN;
IMMUNOGLOBULIN G2;
LAMIVUDINE;
NUCLEOTIDE DERIVATIVE;
OSELTAMIVIR;
PENCICLOVIR;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
RUPINTRIVIR;
STAVUDINE;
TENOFOVIR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALACICLOVIR;
VALGANCICLOVIR;
ZALCITABINE;
ZANAMIVIR;
ZIDOVUDINE;
ANTIVIRAL ACTIVITY;
DRUG MECHANISM;
DRUG METABOLISM;
EDITORIAL;
ENZYME INHIBITION;
HUMAN;
POLYPHARMACY;
VIRUS INFECTION;
VIRUS INHIBITION;
ACETAMIDES;
ANTIVIRAL AGENTS;
CD4 IMMUNOADHESINS;
GUANIDINES;
HIV ENVELOPE PROTEIN GP41;
HUMANS;
ISOXAZOLES;
OSELTAMIVIR;
PEPTIDE FRAGMENTS;
PYRANS;
PYRROLIDINONES;
SIALIC ACIDS;
ZANAMIVIR;
|
EID: 0034770592
PISSN: 10529276
EISSN: None
Source Type: Journal
DOI: 10.1002/rmv.330 Document Type: Editorial |
Times cited : (1)
|
References (16)
|